FibroGen (FGEN) Tops Q3 EPS by 3c

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.65), $0.03 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $36.84 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
• MSC Industrial (MSM) Tops Q3 EPS by 17c, Beats on Revenue